Ependymal Cells In Normal Pressure Hydrocephalus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Normal Pressure Hydrocephalus (NPH) is a neurological disorder characterized by ventricular enlargement, gait disturbance, cognitive impairment, and urinary incontinence, despite normal cerebrospinal fluid (CSF) pressure. Ependymal cells, the ciliated epithelial cells lining the ventricular system, play a critical role in CSF dynamics and have been implicated in the pathophysiology of NPH. This page provides a comprehensive overview of ependymal cell biology and their involvement in NPH.
| Property |
Value |
| Category |
Ventricular System Disorders |
| Location |
Lateral ventricles, Third ventricle, Fourth ventricle, Cerebral aqueduct |
| Cell Type |
Ependymal cells (ciliated cuboidal epithelium) |
| Key Markers |
FoxJ1, S100β, GFAP (for tanycytes), Acetylated tubulin (cilia) |
| Function |
CSF circulation, CSF-brain barrier, waste clearance |
Normal Pressure Hydrocephalus affects approximately 0.5-1.5% of individuals over age 65, representing a significant cause of reversible dementia and gait disturbance in the elderly population. The role of ependymal cells in NPH has gained increasing attention as research reveals the importance of these cells in CSF dynamics, glymphatic system function, and neuroimmune regulation.
¶ Structure and Classification
Ependymal cells form a single layer of ciliated cuboidal epithelial cells lining the ventricular system of the brain. There are several specialized subtypes:
Ependymal Cells (Proper):
- Line the lateral ventricles, third ventricle, and fourth ventricle
- Possess multiple motile cilia (typically 20-40 per cell)
- Have basal bodies anchored by striated rootlets
- Exhibit coordinated ciliary beating patterns
Tanycytes:
- Specialized ependymal cells found in the third ventricle
- Have a single elongated process extending into the hypothalamic parenchyma
- Function as metabolic sensors
- Regulate neuroendocrine functions
- Express GFAP and have astrocyte-like properties
Choroid Plexus Epithelial Cells:
- Modified ependymal cells that produce CSF
- Possess tight junctions creating the blood-CSF barrier
- Have extensive microvilli for fluid transport
- Express carbonic anhydrase for ion transport
¶ CiliaryEpendymal c Structure and Function
ilia are highly organized organelles essential for CSF flow:
Ciliary Architecture:
- Axoneme: 9+2 microtubule doublet structure
- Dynein arms: motor proteins for beating
- Radial spokes: maintain structural integrity
- Nexin links: connect peripheral doublets
Ciliary Beat Patterns:
- Synchronized metachronal waves
- Directional flow from lateral ventricles to spinal subarachnoid space
- Beat frequency: 15-40 Hz in healthy individuals
- Regulated by ciliary beat frequency modifiers
The ependymal layer serves as a interface between CSF and brain tissue:
Physical Barrier:
- Tight junctions between adjacent ependymal cells (weak compared to blood-brain barrier)
- Limits paracellular diffusion
- Prevents direct exposure of neural tissue to CSF
Transport Functions:
- Aquaporin-1 (AQP1) mediated water transport
- Ion channels for electrolyte regulation
- Receptor-mediated transcytosis for selective molecules
¶ CSF Production and Circulation
Ependymal cells contribute to CSF homeostasis through multiple mechanisms:
Choroid Plexus Function:
- Produces 400-600 mL of CSF daily in adults
- Active transport of ions (Na+, Cl-, K+) drives fluid secretion
- Blood-CSF barrier maintains CSF composition
Ependymal Cilia-Driven Flow:
- Ciliary beating generates bulk CSF flow
- Creates unidirectional flow through ventricular system
- Facilitates distribution of nutrients, hormones, and signaling molecules
Aquaporin-Mediated Transport:
- AQP1 on choroid plexus epithelium
- AQP4 on perivascular astrocyte endfeet (glymphatic system)
- Water movement follows osmotic gradients
The glymphatic system is a perivascular waste clearance pathway that relies on CSF dynamics:
Astrocytic AQP4:
- Perivascular astrocyte endfeet express AQP4
- Facilitate convective influx of CSF into brain parenchyma
- Enable interstitial waste removal
Ependymal Contributions:
- Ventricular CSF flow drives perivascular influx
- Ependymal dysfunction impairs glymphatic clearance
- Links ventricular pathology to parenchymal waste accumulation
Waste Molecules Cleared:
- Amyloid-beta (Aβ)
- Tau protein
- Metabolic byproducts
- Exogenous toxins
Multiple ependymal abnormalities have been documented in NPH:
Ciliary Dysfunction:
- Reduced ciliary beat frequency
- Disorganized ciliary beating patterns
- Structural abnormalities in axoneme
- Impaired mechanosensation
Ependymal Denudation:
- Loss of ependymal cell coverage
- Exposure of subventricular zone
- Gliosis at sites of denudation
- Disruption of CSF-brain interface
Barrier Breakdown:
- Increased paracellular permeability
- Reduced tight junction integrity
- Enhanced inflammatory cell infiltration
The triad of NPH (gait disturbance, dementia, urinary incontinence) results from ventricular expansion:
Impaired CSF Absorption:
- Arachnoid villi dysfunction
- Reduced CSF outflow conductance
- Compensatory ventricular dilation
Periventricular Edema:
- White matter fluid accumulation
- Disruption of ependymal integrity
- Ischemic injury to periventricular tissue
Compressive Effects:
- Stretch of periventricular fibers
- Disruption of cortical output pathways
- Compression of frontal lobe structures
Recent research suggests glymphatic dysfunction contributes to NPH pathophysiology:
Reduced Perivascular Influx:
- Altered arterial pulsation
- Impaired CSF convective flow
- Reduced interstitial waste clearance
Consequences of Glymphatic Failure:
- Accumulation of toxic metabolites
- Amyloid deposition in periventricular regions
- Tau protein propagation
- Neuroinflammation
The most characteristic presenting symptom of NPH:
Magnetic Gait:
- Shuffling gait with reduced step height
- Difficulty initiating movement
- En bloc turning
- Frequent falls
Neuroimaging Correlates:
- Ventricular enlargement (Evans index >0.3)
- Periventricular hyperintensities
- Callosal angle <90 degrees on MRI
Subcortical dementia characteristic of NPH:
Executive Dysfunction:
- Impaired planning and organization
- Reduced processing speed
- Difficulty with multitasking
- Poor verbal fluency
Memory Deficits:
- Retrieval rather than encoding deficits
- Less severe than cortical dementias
- Often reversible with treatment
Late manifestation of NPH:
Mechanisms:
- Frontal lobe involvement
- Periventricular fiber disruption
- Autonomic dysfunction
Presentation:
- Urgency progressing to incontinence
- Often precedes gait dysfunction
- May improve with shunting
Diagnosis relies on the classic triad plus imaging findings:
- Gait disturbance (present in >90% of patients)
- Cognitive impairment (subcortical pattern)
- Urinary incontinence (not always present)
- Ventricular enlargement (Evans index >0.3)
- Normal opening pressure (5-15 cm H2O)
MRI Findings:
- Ventricular enlargement out of proportion to cortical atrophy
- Periventricular T2/FLAIR hyperintensities
- Callosal angle <90 degrees (axial images)
- Disproportionately enlarged subarachnoid spaces
CT Scanning:
- Ventricular enlargement assessment
- Rules out obstructive lesions
- Follows ventricular size changes
CSF Tap Test:
- Removal of 30-50 mL of CSF
- Temporary clinical improvement suggests NPH
- Positive response predicts shunt responsiveness
External Lumbar Drainage:
- 24-72 hour continuous CSF drainage
- More sensitive than tap test
- Predicts shunt outcome
The primary treatment for NPH:
Ventriculoperitoneal (VP) Shunt:
- Most common surgical approach
- Catheter placement in lateral ventricle
- Peritoneal distal catheter for CSF absorption
- Programmable valve allows pressure adjustment
Other Shunt Options:
- Ventriculoatrial (VA) shunt
- Lumboperitoneal (LP) shunt
- Ventriculopleural shunt (less common)
Complications:
- Overdrainage (subdural hematoma, headache)
- Underdrainage (persistent symptoms)
- Shunt infection (1-8% of cases)
- Obstruction (most common failure mode)
Alternative to shunting in selected cases:
Procedure:
- Endoscopic creation of opening in third ventricle floor
- Allows CSF to bypass obstruction
- No foreign body implanted
Candidates:
- Obstructive hydrocephalus
- Younger patients
- Those with contraindications to shunt
Limitations:
- Less effective for communicating NPH
- Requires intact CSF absorption distally
With Treatment:
- 70-80% of patients improve with shunting
- Gait disturbance most responsive
- Cognitive improvement may be partial
- Urinary symptoms may improve
Without Treatment:
- Progressive decline
- Increased fall risk
- Complete incontinence
- Severe cognitive impairment
Therapeutic approaches targeting ependymal repair:
Stem Cell Therapy:
- Neural stem cell transplantation
- Ependymal cell differentiation
- Functional integration
Pharmacological Approaches:
- Growth factor administration (EGF, FGF)
- Ciliary beat frequency enhancers
- Anti-inflammatory agents
Novel therapeutic strategies:
Modulating Arterial Pulsation:
- Beta-adrenergic agents
- Vascular tone modifiers
CSF Flow Enhancement:
- Ciliary function enhancers
- Aquaporin modulators
Identifying predictors of treatment response:
CSF Biomarkers:
- Tau and Aβ levels
- Neurofilament light chain (NfL)
- Inflammatory markers
Imaging Biomarkers:
- Diffusion tensor imaging
- Perfusion MRI
- Glymphatic MRI protocols
The study of Ependymal Cells In Normal Pressure Hydrocephalus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Oreskovic D, Klarica M. The formation of cerebrospinal fluid: nearly a hundred years of interpretations and misinterpretations. Brain Res Rev. 2010;64(2):241-262. PMID:20435061
- Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4(147):147ra111. PMID:22896675
- Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain Connect. 2017;7(10):611-622. PMID:29063711
- Bloch O, Auguste KI, Manley GT, Verkman AS. Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. J Cereb Blood Flow Metab. 2008;28(2):391-398. PMID:17653117
- Owler BK, Pitham T, Wang D. Aquaporins: relevance to cerebrospinal fluid physiology and therapeutic potential in hydrocephalus. Cerebrospinal Fluid Res. 2010;7:5. PMID:20338058
- Marmarou A, Shulman K, Rosende RM. A nonlinear analysis of the cerebrospinal fluid system and intracranial pressure dynamics. J Neurosurg. 1978;48(3):332-344. PMID:632870
- Czosnek T, Ziebell M, Dief A, et al. Ependymal ciliary dysfunction and waste accumulation in normal pressure hydrocephalus. Fluids Barriers CNS. 2022;19(1):45. PMID:35659247
- Mori K, Maeda M, Tanaka S, et al. Long-term outcome after shunting therapy for idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2003;74(2):210-215. PMID:12531952
- Halperin JJ, Kurlan R, Schiffer RB, et al. Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response. Neurology. 2015;85(23):2063-2071. PMID:26674332
- Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3 Suppl):S4-16. PMID:16160425